Envestnet Asset Management Inc. trimmed its holdings in SPDR S&P Biotech ETF ( NYSEARCA:XBI – Free Report ) by 32.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission.
The institutional investor owned 134,779 shares of the exchange traded fund’s stock after selling 65,481 shares during the period. Envestnet Asset Management Inc. owned 0.
18% of SPDR S&P Biotech ETF worth $12,138,000 as of its most recent SEC filing. A number of other hedge funds and other institutional investors have also modified their holdings of XBI. Wedbush Securities Inc.
boosted its holdings in shares of SPDR S&P Biotech ETF by 6.6% during the 4th quarter. Wedbush Securities Inc.
now owns 6,582 shares of the exchange traded fund’s stock worth $593,000 after buying an additional 405 shares during the period. ExodusPoint Capital Management LP bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $6,027,000. World Investment Advisors bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $762,000.
OLD Mission Capital LLC grew its position in shares of SPDR S&P Biotech ETF by 477.4% in the fourth quarter. OLD Mission Capital LLC now owns 13,904 shares of the exchange traded fund’s stock valued at $1,252,000 after purchasing an additional 11,496 shares during the last quarter.
Finally, StoneX Group Inc. bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $2,352,000. SPDR S&P Biotech ETF Stock Performance NYSEARCA XBI opened at $75.
93 on Friday. The stock has a 50-day simple moving average of $84.02 and a 200 day simple moving average of $91.
31. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $105.
47. The stock has a market capitalization of $4.79 billion, a PE ratio of 11.
47 and a beta of 1.00. SPDR S&P Biotech ETF Profile SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index.
The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. See Also Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.
com's FREE daily email newsletter ..
Business
Envestnet Asset Management Inc. Sells 65,481 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Envestnet Asset Management Inc. trimmed its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 32.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 134,779 shares of the exchange traded fund’s stock after selling 65,481 shares during the period. Envestnet Asset [...]